Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Keiichi Maruyama is active.

Publication


Featured researches published by Keiichi Maruyama.


Japanese Journal of Cancer Research | 1990

Early Gastric Cancer Induced by N-Ethyl-N′-nitro-N-nitrosoguanidine in a Cynomolgus Monkey Six Years after Initial Diagnosis of the Lesion

Zoltan Szentirmay; Hiroko Ohgaki; Keiichi Maruyama; Hiroyasu Esumi; Shozo Takayama; Takashi Sugimura

ABSTRACT A signet ring cell carcinoma in the gastric antrum of a Cynomolgus monkey induced by N‐ethyl‐N′‐nitro‐N‐nitrosoguanidine was sequentially studied by endoscopy, biopsy, and autopsy. The carcinoma was first detected on the angulus of the stomach at the 38th month as a slightly elevated lesion. Sixty‐one months later this tumor was found to be still in the “early”(intramucosal) stage. Another, independent, initial gastric cancer was also discovered. This is the first example of an induced gastric carcinoma remaining in the “early’stage during a six‐year follow‐up period after the initial histologic diagnosis.


Japanese Journal of Cancer Research | 1990

Analysis of Stomach Cancer Incidence by Histologic Subtypes Based on a Mathematical Model of Multistage Cancer Induction and Exponential Growth

Naohito Yamaguchi; Shaw Watanabe; Keiichi Maruyama; Toshiteru Okubo

A mathematical model incorporating the processes of both cancer induction and subsequent tumor growth has been developed. The model was applied to incidence data of stomach cancer classified into histologic subtypes: papillary adenocarcinoma (PAP), well and moderately differentiated tubular adenocarcinomas (WEL and MOD), poorly differentiated adenocarcinoma (POR), mucinous adenocarcinoma (MUC) and signet‐ring cell carcinoma (SIG). The multistage theory was assumed for cancer induction as in the Armitage‐Doll model. For the period of growth, exponential growth was assumed and clinical surfacing was formulated as a stochastic process related to tumor diameter. The number of stages in cancer induction and the tumor growth rate were simultaneously estimated for each histologic subtype using the maximum likelihood procedure. The present model showed better fits than the Armitage‐Doll model in most histologic subtypes except WEL. PAP, WEL and MOD, which are characterized as differentiated subtypes with less mucous production, showed different features from POR, MUC and SIG: 1) the number of stages was estimated to be larger, 2) the differences in incidence rates between males and females were more marked, and 3) males tended to have larger growth rates in PAP and MOD, while in POR, MUC and SIG, females had larger values. The present study showed that an analysis by histologic subtypes is of importance in stomach cancer and that the period of tumor growth should not be ignored when formulating a model of the natural history of stomach cancer.


Japanese Journal of Clinical Oncology | 1980

Gastrin-Enhanced Tumor Growth of a Xenotransplantable Human Gastric Carcinoma in Nude Mice

Hisanao Ohkura; Kazuko Hanafusa; Keiichi Maruyama; Hisazo Kitaoka; Shaw Watanabe; Toru Kameya


Japanese Journal of Clinical Oncology | 1985

Characteristics of Gastric Cancer Invading to the Proper Muscle Layer—with Special Reference to Mortality and Cause of Death—

Kenzo Yoshikawa; Keiichi Maruyama


Japanese Journal of Cancer Research | 1985

Gastric cancer risk factors: a case-control study based on medical records.

Hiroshi Hoshino; Takeshi Hirayama; Hiroko Arimoto; Keiichi Maruyama; Hisazo Kitaoka; Tatsuya Yamada; Teruyuki Hirota; Shaw Watanabe; Mitsuru Tanaka; Shinji Suzuki


Japanese Journal of Clinical Oncology | 1979

Clinical Trials of a New Anticancer Drug, 1-Hexylcarbamoyl-5-fluorouracil

Kenzo Okabayashi; Yasuo Koyama; Keiichi Maruyama; Nobuo Okazaki; Teruo Sakano; Toru Ise


Japanese Journal of Clinical Oncology | 1982

Antitumor Effect of 3-[(4-Amino-2-Methyl-5-Pyrimidinyl) Methyl]-1-(2-Chloroethyl)-1-Nitrosourea (ACNU) on Human Colon Carcinomas Transplanted into Nude Mice

Tetsuro Kubota; Yuji Hanatani; Ken Tsuyuki; Munehiko Nakada; Fumiki Asanuma; Masaichi Okazaki; Kyuya Ishibiki; Osahiko Abe; Eiichi Nakajima; Keiichi Maruyama


Japanese Journal of Clinical Oncology | 1989

Workshop for the evaluation of survival trends for cancer patients.

Shaw Watanabe; Akira Oshima; Isaburo Fujimoto; Tatsuo Wada; Keiichi Maruyama


Japanese Journal of Clinical Oncology | 1985

Estimation of the prevalence of occult cancer and its application to the epidemiology of multiple primary cancer.

Naohito Yamaguchi; Shaw Watanabe; Keiichi Maruyama; Okubo T


Japanese Journal of Cancer Research | 1985

GASTRIC CANCER RISK FACTORS

Hiroshi Hoshino; Takeshi Hirayama; Hiroko Arimoto; Keiichi Maruyama; Hisazo Kitaoka; Tatsuya Yamada; Teruyuki Hirota; Shaw Watanabe; Mitsuru Tanaka; Shinji Suzuki; Kaoru Aihara

Collaboration


Dive into the Keiichi Maruyama's collaboration.

Top Co-Authors

Avatar

Shaw Watanabe

Tokyo University of Agriculture

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Teruyuki Hirota

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiroyasu Esumi

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge